NewDays raises $16M seed
Announced 2 September 2026
◆ The Round
NewDays raised $16M in seed funding, announced on 2 September 2026, led by Madrona, General Catalyst. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.
◆ About NewDays
NewDays is a Seattle-based startup developing an AI-driven telehealth platform for dementia care combining human clinical sessions with an AI companion to provide cognitive therapy for patients with mild dementia and cognitive impairment. NewDays is based in United States and currently at seed stage, operating in Digital Health, Healthtech Infrastructure.
◆ Investors
LeadMadrona, General Catalyst
◆ Investing funds on Raise
◆ Market context
General Catalyst is profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links NewDays's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.
◆ Explore the market
◆ FAQ
How much did NewDays raise?
NewDays raised $16M in its seed round, announced 2026-09-02.
Who invested in NewDays's seed round?
The round was led by Madrona and General Catalyst.
What does NewDays do?
NewDays is a Seattle-based startup developing an AI-driven telehealth platform for dementia care combining human clinical sessions with an AI companion to provide cognitive therapy for patients with mild dementia and cognitive impairment.
Verified 3 September 2026 · Sources: public filings